| Nadrienne A Pinnock, | |
|
3301 E 12th St, Oakland, CA 94601-3424 | |
| (510) 269-9030 | |
| Not Available |
| Full Name | Nadrienne A Pinnock |
|---|---|
| Gender | Female |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 3301 E 12th St, Oakland, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013698976 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | (* (Not Available)) | Secondary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nadrienne A Pinnock, 3301 E 12th St, Oakland, CA 94601-3424 Ph: (347) 385-3053 | Nadrienne A Pinnock, 3301 E 12th St, Oakland, CA 94601-3424 Ph: (510) 269-9030 |
News Archive
Synthes, Inc. (SWX: SYST.VX), a leading global medical device company in the orthopaedic trauma, spine, and cranio-maxillofacial markets, and Kensey Nash Corporation (Nasdaq: KNSY), a leading developer and manufacturer of innovative regenerative medicine products, today announced a strategic agreement for products developed from Kensey Nash's unique extracellular matrix (ECM) technology.
An individual's reason for undergoing a medical intervention - be it to prevent or treat disease, earn money, or to have a child - may result in variations in the bodily experience of the patient, Yale researchers have found.
VTT Technical Research Centre of Finland and A*STAR Agency for Science, Technology and Research from Singapore have developed remote healthcare services that allow patients to be treated globally independent of time and location and irrespective of the solutions provided by hardware and data system suppliers. In Finland, the first trial services for treating cardiac patients and patients suffering from chronic illnesses have been promising.
Researchers have long understood that genetics can play a role in how susceptible people are to contracting cholera, but a team of Harvard scientists is now uncovering evidence of genetic changes that might also help protect some people from contracting the deadly disease.
There are more and more examples of the ways in which we can benefit from our bacteria. According to researcher Rolf Lood from Lund University in Sweden, this is true for the skin as well.
› Verified 2 days ago